Oral Delivery of Puerarin Nanocrystals To Improve Brain Accumulation and Anti-Parkinsonian Efficacy

Molecular Pharmaceutics
Sha XiongTongkai Chen

Abstract

Puerarin (PU) has emerged as a promising herb-derived anti-Parkinsonism compound. However, the undesirable water solubility as well as the unwanted bioavailability of PU limit its application. Therefore, this study aimed to develop and characterize PU nanocrystals (PU-NCs) with enhanced oral bioavailability and improved brain accumulation for the treatment of Parkinson's disease (PD). The fabricated PU-NCs were approximately spherical, with a mean size of 83.05 ± 1.96 nm, a PDI of 0.047 ± 0.009, a drug loading of 72.7%, and a rapid dissolution rate in vitro. Molecular dynamics simulation of PU and Pluronic F68 demonstrated the interaction energy and binding energy of -88.1 kJ/mol and -40.201 ± 0.685 kJ/mol, respectively, indicating a spontaneous binding with van der Waals interactions. In addition, the cellular uptake and permeability of PU-NCs were significantly enhanced as compared to PU alone ( p < 0.01). Moreover, PU-NCs exerted a significant neuroprotective effect against the cellular damage induced by the 1-methyl-4-phenylpyridinium ion (MPP+). Besides, PU-NCs demonstrated no obvious toxic effects on zebrafish, as evidenced by the unaltered morphology, hatching, survival rate, body length, and heart rate. Fluorescence res...Continue Reading

References

Sep 25, 2012·International Journal of Pharmaceutics·Jan P Möschwitzer
Jan 22, 2013·International Journal of Pharmaceutics·Biswadip SinhaJan P Möschwitzer
Nov 5, 2013·International Journal of Pharmaceutics·Wei LiLiang Fang
Jan 1, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ying LuMichael Sturek
Jan 7, 2014·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Lieselotte De SmetJean Paul Remon
Mar 13, 2014·International Journal of Pharmaceutics·Hewei LiYanjiang Qiao
Mar 29, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Vivek K PawarManish K Chourasia
May 13, 2014·International Journal of Pharmaceutics·Xuezhen ZhaiRainer H Müller
Jun 28, 2014·Chinese Journal of Natural Medicines·Shu-Yong WeiXiao-Yu Xu
Apr 18, 2015·Reproductive Toxicology·Aline Haab LutteRosane Souza Da Silva
Apr 24, 2015·Lancet·Lorraine V Kalia, Anthony E Lang
Aug 2, 2015·Colloids and Surfaces. B, Biointerfaces·Marek PiotrowskiPiotr Warszyński
Sep 19, 2015·International Journal of Pharmaceutics·Juan DuYancai Wang
Dec 19, 2015·International Journal of Pharmaceutics·Chen ChenYing Zheng
Aug 26, 2016·Nanomedicine : Nanotechnology, Biology, and Medicine·Lulu WangYancai Wang
Feb 27, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Zhaoqiang DongQinghua Lu
Mar 8, 2017·Colloids and Surfaces. B, Biointerfaces·Pulkit Khatri, Jun Shao
Jun 18, 2017·AAPS PharmSciTech·Saad M AlshahraniFaiyaz Shakeel
Nov 14, 2017·Journal of Controlled Release : Official Journal of the Controlled Release Society·Dengning XiaYong Gan
Nov 21, 2017·Colloids and Surfaces. B, Biointerfaces·Xuqi KangYongzhong Du
Mar 3, 2018·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Mayank Kumar SinghRamakrishna Sistla
Jun 2, 2018·BioMed Research International·Mengmeng ZhengChunchao Han

❮ Previous
Next ❯

Citations

Nov 4, 2020·Journal of Neurology·Jonathan BaskinSimon J G Lewis
Mar 1, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·Guangshuai ZhangQiang Fu
Aug 8, 2021·Nanomaterials·Alba Pensado-LópezFernando Torres Andón

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.